Skip to main content
. 2015 Nov 25;120(4):416–425. doi: 10.1152/japplphysiol.00879.2015

Table 4.

Safety and tolerability

Placebo Nitrite 80 mg/day Nitrite 160 mg/day
Average peak blood methemoglobin, % 0.68 ± 0.04 0.74 ± 0.06 1.10 ± 0.06
Peak blood methemoglobin, % 1.0 1.1 1.5
Treatment-emergent adverse events, n
    Headache 1 0 3
    Nausea 1 0 0
    Fatigue 0 2 2
    Dizziness/lightheadedness 1 1 2
    Asymptomatic orthostatic intolerance 1 1 1
    Dry mouth 1 0 0
Subjects with ≥1 adverse events, n 2 4 4
Dropouts, n 1 0 1

Applicable values are means ± SE.